Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based CMO’ operating in the Health Care space. If you think a CMO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Aris Papageorghiou
Co-Founder & CMO of Intelligent Ultrasound
Aris Papageorghiou is the Professor of Fetal Medicine at University of Oxford.
Follow Aris Papageorghiou:
About Intelligent Ultrasound, Royal College of Obstetricians and Gynaecologists, St Georges University Hospitals NHS Foundation Trust, Ultrasound Diagnostic Services, University of Oxford: Intelligent Ultrasound develops software that improves the quality, reliability, and diagnostic power of medical ultrasound.
Sally Scott
CMO of Advanced
Sally Scott is Chief Marketing Officer at Advanced, having been promoted to the role in December 2015. She had previously been marketing director of its Business Solutions division, delivering a breadth of back office and specialist CRM solutions to the mid and enterprise market. Sally is now responsible for aligning the company’s marketing initiatives and brand awareness to its ambitious growth plans. Sally is passionate about ensuring that marketing makes a real and measurable contribution to sales revenue and is responsible for delivering the company’s integrated new brand, launched in April 2016 as part of the company’s transformation process. Sally brings over 15 years of senior marketing experience to Advanced. Prior to Advanced, she was head of marketing at UNIT 4.
Follow Sally Scott:
About Advanced, Advanced: Advanced provide software & services for commercial, public and third sector organisations that make the complex simple.
Sally Scott
CMO of Advanced
Sally Scott is Chief Marketing Officer at Advanced, having been promoted to the role in December 2015. She had previously been marketing director of its Business Solutions division, delivering a breadth of back office and specialist CRM solutions to the mid and enterprise market. Sally is now responsible for aligning the company’s marketing initiatives and brand awareness to its ambitious growth plans. Sally is passionate about ensuring that marketing makes a real and measurable contribution to sales revenue and is responsible for delivering the company’s integrated new brand, launched in April 2016 as part of the company’s transformation process. Sally brings over 15 years of senior marketing experience to Advanced. Prior to Advanced, she was head of marketing at UNIT 4.
Follow Sally Scott:
About Advanced, Advanced: Advanced provide software & services for commercial, public and third sector organisations that make the complex simple.
Alastair MacKinnon
CMO and Co-Founder of Mereo Biopharma
Alastair joined the team in 2005. He serves as Board Observer for Albireo and Chroma. Further to these he has been actively involved in the investments in OncoMed (OMED), Proteolix and Nabriva. Prior to joining, Alastair was a practising physician, with a breadth of experience across cardiovascular and oncology surgery and intensive care. He holds a Physiology BSc (Hons) and MBBS from King’s College London, is a Member of the Royal College of Surgeons (Ed) and hold s a Diploma in Corporate Finance from the London Business School.
Follow Alastair MacKinnon:
About Mereo Biopharma: Mereo is a new UK-based speciality biopharmaceutical company.
Alan Davies
CMO of Edinburgh Molecular Imaging
Over 25 years-experience as a Medical Director in the pharmaceutical and med tech industry, working globally to address major health issues including early cancer detection, most recently as CMO for GE Healthcare.
Follow Alan Davies:
About Edinburgh Molecular Imaging: Edinburgh Molecular Imaging is a developer of optical molecular imaging technology.
Alan Davies
CMO of Edinburgh Molecular Imaging
Over 25 years-experience as a Medical Director in the pharmaceutical and med tech industry, working globally to address major health issues including early cancer detection, most recently as CMO for GE Healthcare.
Follow Alan Davies:
About Edinburgh Molecular Imaging: Edinburgh Molecular Imaging is a developer of optical molecular imaging technology.
Pavel Pisa
CMO of Crescendo Biologics
Before joining Crescendo, Pavel was the Head of Translational Medicine at Roche and Genentech where he led over 50 programs through early and late clinical development. As both a physician and a scientist, he has in-depth knowledge of the real-life experimental and clinical challenges associated with delivering highly innovative medicines and has successfully translated scientific findings into transformative medicines such as Avastin and Gazyva, leading to significant improvement in the lives of cancer patients. Pavel has a distinguished academic, clinical and scientific career at world-leading medical institutions. He was Professor of Clinical Experimental Oncology at the Karolinska Institutet, Stockholm and has held positions at NIH, MD Anderson Cancer Center and Scripps Research Institute. He is the author of 115 highly-cited publications and patents within tumour immunology. Pavel holds a medical degree and a doctorate in medicine in Natural Killer Cells in the clinic from Charles University, Prague, as well as a PhD in Immunology from the Karolinska Institutet.
Follow Pavel Pisa:
About Crescendo Biologics: Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.
Tony Wilcox
Chief Marketing & Commercial Officer of Neurovalens
Follow Tony Wilcox:
About Henley Investment, ModiusHealth, Neurovalens: Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology
Richard Bambury
Co-Founder & CMO of ONCOassist® (Portable Medical Technology Ltd.)
Richard is a medical oncologist at Memorial Sloan Kettering Cancer Center in NYC. He is heavily involved in patient care and academic research. He is the recipient of numerous awards including the the Ainsworth Scholarship from UCC in 2012, the John Quale Travel fellowship in 2013 and is a lead co-investigator on a Prostate Cancer Foundation-Movember Challenge Award worth $1 million in 2014. In his career to date he has presented over 40 original research abstracts at national and international oncology conferences including ESMO, ASCO and ASCO GU. His work has been published in peer reviewed journals including the New England Journal of Medicine. He is dedicated to improving cancer patient care through ongoing innovation and research.
Follow Richard Bambury:
About ONCOassist® (Portable Medical Technology Ltd.): The go-to app for oncology professionals.
Peter Grinbergs
CMO and Co-Founder of EQL
Follow Peter Grinbergs:
About EQL: EQL specializes in the fields of AI, machine learning, physiotherapy, insurance, heathtech, and digital health.
Paul Leeson
CMO of Ultromics
Paul is Professor of Cardiovascular Medicine at the University of Oxford and and Director of the Oxford Cardiovascular Clinical Research Facility. Following a MB/PhD at Cambridge and research at UCL in London, he moved to Oxford and set up a clinical research programme to pioneer the use of novel imaging approaches for prevention of cardiovascular disease. He is also involved in some of the largest cardiovascular imaging research studies in the world and is lead author of Echocardiography, the best selling training handbook for echocardiographers.
Follow Paul Leeson:
About Ultromics: Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.
Neal L Millar
Co Founder & CMO of Causeway Therapeutics
Neal is an Academic Consultant Orthopaedic Surgeon specialising in shoulder surgery having completed fellowships in Sydney and New York and is an expert in human tendinopathy.
Follow Neal L Millar:
About Causeway Therapeutics, University of Glasgow, University of Glasgow: A bio pharmaceutical spin out emerging.
Vivek Patkar
CMO of DEONTICS
Vivek Patkar is a Founder & Chief Medical Officer at DEONTICS.
Follow Vivek Patkar:
About DEONTICS: Deontics was set up to commercialise Clinical Quality and Clinical Decision Support Technologies
Epistimi Sachitzi
CMO and Co-founder of Blueline
Follow Epistimi Sachitzi:
About Blueline: BlueLine is a startup aiming to revolutionize primary healthcare using mobile tech to connect patients with healthcare professionals.
Matt Boyles
Director of Sales and Marketing & CMO of Wireless Fitness
Follow Matt Boyles:
About Wireless Fitness: The Wireless Fitness is an app that portable exercise studio in your phone
Matt Boyles
Director of Sales and Marketing & CMO of Wireless Fitness
Follow Matt Boyles:
About Wireless Fitness: The Wireless Fitness is an app that portable exercise studio in your phone
